Purchases and Sales Made in Q3 2023 in Anebulo Pharmaceuticals, Inc. (ANEB)
This table provides information about the institutional ownership of Anebulo Pharmaceuticals, Inc. (ANEB) during Q3 2023. The information is specifically focused on institutions that hold shares of Anebulo Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
14.8K+ 241.76% |
$31.7K - $51.5K
|
20.9K
$33.8K
|
|
|
Nov 14, 2023
Q3 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
6.31K+ 39.37% |
$13.6K - $22K
|
22.3K
$36.2K
|
|
|
Nov 14, 2023
Q3 2023
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
- |
1.66K+ 9.58% |
$3.57K - $5.79K
|
19K
$30.7K
|
|
|
Nov 14, 2023
Q3 2023
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
- |
1.66K+ 1.06% |
$3.57K - $5.79K
|
158K
$256K
|
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1+ 1.75% |
$2.15 - $3.49
|
58
$94
|
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Praetorian Pr LLC
Rincon, PR |
SELL
|
- |
-2.71K- 1.51% |
$5.83K - $9.47K
|
177K
$287K
|
|
|
Nov 13, 2023
Q3 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-3.06K- 42.19% |
$6.58K - $10.7K
|
4.19K
$6.79K
|